EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality

Chenlu Wei iD, Xinxin Zeng iD, Keer Wang, Mengchen Wang, Min Lei, Zhenye Zhu, Yining Xu, Yanqing Zhao, Qingling Yang iD, Yingpu Sun iD

Reproduction · 2025

DOI: 10.1530/rep-24-0350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction, 2025. Verfasst von Chenlu Wei und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Niacinamide, Oocytes, Diabetes Mellitus, Experimental, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In brief NAD+ levels were reduced in streptozotocin (STZ)-induced diabetic mice, but nicotinamide riboside (NR) supplementation improved these levels in diabetic ovaries and oocytes, enhancing oocyte quality and early embryo development by improving mitochondrial function and lowering reactive oxygen species (ROS) levels. Abstract Diabetes mellitus is strongly correlated with a decline in oocyte quality; however, noninvasive and effective methods to improve this issue have yet to be fully development. Here, we demonstrate that in vivo supplementation with NR 400 mg/kg/day for 14 days effectively enhances the quality of oocytes from diabetic mice induced by streptozocin 190 mg/kg by restoring nicotinamide adenine dinucleotide (NAD+) levels. NR supplementation not only improved superovulation function of diabetic mice but also improved their oocyte quality and embryonic development potential after fertilization by maintaining normal spindle structure and alleviating mitochondrial dysfunction. In addition, NR supplementation reduced ROS levels in oocytes from diabetic mice. Overall, our findings suggest that dietary NR supplementation is a viable strategy to protect oocytes from diabetes-related deterioration, thereby enhancing reproductive outcomes in maternal diabetes and improving the efficacy of assisted reproductive technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiacinamideOocytesDiabetes Mellitus, ExperimentalDietary SupplementsAnimalsFemaleMiceReactive Oxygen SpeciesPregnancyPyridinium CompoundsEmbryonic DevelopmentMitochondriaNAD

Stichwörter der Autor:innen

diabetes mellitusinfertilitymitochondrianicotinamide adenine dinucleotide (NAD+)nicotinamide riboside (NR)oocyte

Substanzen

Niacinamidenicotinamide-beta-ribosideReactive Oxygen SpeciesPyridinium CompoundsNAD

Autor:innen und Institutionen

ORCID-Profile: Chenlu Wei, Xinxin Zeng, Qingling Yang, Yingpu Sun

Zitieren

APA

Wei, C., Zeng, X., Wang, K., Wang, M., Lei, M., Zhu, Z., Xu, Y., Zhao, Y., Yang, Q., & Sun, Y. (2025). Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality. Reproduction. https://doi.org/10.1530/rep-24-0350

Vancouver

Wei C, Zeng X, Wang K, Wang M, Lei M, Zhu Z, et al. Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality. Reproduction. 2025. doi:10.1530/rep-24-0350

BibTeX
@article{Wei2025,
  author = {Wei, Chenlu and Zeng, Xinxin and Wang, Keer and Wang, Mengchen and Lei, Min and Zhu, Zhenye and Xu, Yining and Zhao, Yanqing and Yang, Qingling and Sun, Yingpu},
  title = {Nicotinamide riboside supplementation protects against maternal diabetes-associated decline in oocyte quality},
  journal = {Reproduction},
  year = {2025},
  doi = {10.1530/rep-24-0350}
}
Kostenlos starten →